A case of optic neuropathy after short-term linezolid use in a patient with acute lymphocytic leukemi

Clinical Infectious Diseases

Volumn 48, Issue 7, 2009, Pages

  Joshi, Lavnish ^a   Taylor, Simon R J ^a,d   Large, Oliver ^b   Yacoub, Sophie ^c   Lightman, Susan ^a,d,e  

^a Multidisciplinary Vasculitis Clinic   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ASPARAGINASE; C REACTIVE PROTEIN; DAUNORUBICIN; GENTAMICIN; LINEZOLID; MEROPENEM; METHOTREXATE; PIPERACILLIN; RIFAMPICIN; TAZOBACTAM; VANCOMYCIN; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; CANCER CHEMOTHERAPY; CASE REPORT; CHEST INFECTION; CLINICAL FEATURE; DISEASE EXACERBATION; DRUG WITHDRAWAL; EYE EXAMINATION; FEMALE; HOSPITAL ADMISSION; HUMAN; OPTIC NERVE DISEASE; POSTDURAL PUNCTURE HEADACHE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTICEMIA; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION;

ACETAMIDES; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; OPTIC NERVE DISEASES; OXAZOLIDINONES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SEPSIS; YOUNG ADULT;

EID: 63649132248     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597298     Document Type: Article

References (10)

1. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid tor the treatment of multidrug-resistant, grampositive infections: experience from a compassionate-use program. Clin Infect Dis 2003;36:159-68.
2. Javaheri M, Khurana RN, O'Hearn TM, Lai MM, Sadun AA. Linezolid-induced optic neuropathy: a mitochondrial disorder? Br J Ophthalmol 2007;91:111- 5.
3. Azamfirei L, Copotoiu SM, Branzaniuc K, Szederjesi J, Copotoiu R, Berteanu C. Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy. Pharmacoepidemiol Drug Saf 2007; 16:402-4.
4. Davidson SI. Reports of ocular adverse reactions. Trans Ophthalmol Soc U K 1973;93:495-510.
5. Shah CP, McKey J, Spirn MJ, Maguire J. Ocular candidiasis: a review. Br J Ophthalmol 2008;92:466-8.
6. Brown GC, Shields JA, Augsburger JJ, Serota FT, Koch P. Leukemic optic neuropathy. Int Ophthalmol 1981;3:111-6.
7. Saijo T, Hayashi K, Yamada H, Wakamura M. Linezolid-induced optic neuropathy. Am J Ophthalmol 2005;139:1114-6.
8. Shinabarger D, Marotti K, Murray R, et al. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob Agents Chemother 1997;41:2132-6.
9. De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 2006;42:1111-7.
10. Frippiat F, Bergiers C, Michel C, Dujardin J, Derue G. Severe bilateral optic neuritis associated with prolonged linezolid therapy. J Antimicrob Chemother 2004;53:1114-5.